447 related articles for article (PubMed ID: 34863296)
1. A comprehensive comparison between camelid nanobodies and single chain variable fragments.
Asaadi Y; Jouneghani FF; Janani S; Rahbarizadeh F
Biomark Res; 2021 Dec; 9(1):87. PubMed ID: 34863296
[TBL] [Abstract][Full Text] [Related]
2. Physicochemical differences between camelid single-domain antibodies and mammalian antibodies.
Eskier NE; Eskier D; Firuzan E; Uzunlar SK
Turk J Biol; 2023; 47(6):423-436. PubMed ID: 38681780
[TBL] [Abstract][Full Text] [Related]
3. Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.
Bannas P; Hambach J; Koch-Nolte F
Front Immunol; 2017; 8():1603. PubMed ID: 29213270
[TBL] [Abstract][Full Text] [Related]
4. Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments.
Arbabi-Ghahroudi M
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563400
[TBL] [Abstract][Full Text] [Related]
5. Over expression of anti-MUC1 single-domain antibody fragments in the yeast Pichia pastoris.
Rahbarizadeh F; Rasaee MJ; Forouzandeh M; Allameh AA
Mol Immunol; 2006 Feb; 43(5):426-35. PubMed ID: 16337485
[TBL] [Abstract][Full Text] [Related]
6. Nanobodies as versatile tools: A focus on targeted tumor therapy, tumor imaging and diagnostics.
Al-Baradie RS
Hum Antibodies; 2020; 28(4):259-272. PubMed ID: 32831197
[TBL] [Abstract][Full Text] [Related]
7. Application of camelid heavy-chain variable domains (VHHs) in prevention and treatment of bacterial and viral infections.
Wilken L; McPherson A
Int Rev Immunol; 2018 Jan; 37(1):69-76. PubMed ID: 29182399
[TBL] [Abstract][Full Text] [Related]
8. Shark VNAR phage display libraries: An alternative source for therapeutic and diagnostic recombinant antibody fragments.
Manoutcharian K; Gevorkian G
Fish Shellfish Immunol; 2023 Jul; 138():108808. PubMed ID: 37169114
[TBL] [Abstract][Full Text] [Related]
9. Nanobody-based products as research and diagnostic tools.
De Meyer T; Muyldermans S; Depicker A
Trends Biotechnol; 2014 May; 32(5):263-70. PubMed ID: 24698358
[TBL] [Abstract][Full Text] [Related]
10. Expression of single-domain antibody in different systems.
Liu Y; Huang H
Appl Microbiol Biotechnol; 2018 Jan; 102(2):539-551. PubMed ID: 29177623
[TBL] [Abstract][Full Text] [Related]
11. From Llama to Nanobody: A Streamlined Workflow for the Generation of Functionalised VHHs.
Eyssen LE; Ramadurai S; Abdelkarim S; Buckle I; Cornish K; Lin H; Jones AK; Stephens GJ; Owens RJ
Bio Protoc; 2024 Mar; 14(6):e4962. PubMed ID: 38841291
[TBL] [Abstract][Full Text] [Related]
12. Camelid Single-Domain Antibodies: Historical Perspective and Future Outlook.
Arbabi-Ghahroudi M
Front Immunol; 2017; 8():1589. PubMed ID: 29209322
[TBL] [Abstract][Full Text] [Related]
13. Enteric pharmacokinetics of monomeric and multimeric camelid nanobody single-domain antibodies.
Debatis M; Danz H; Tremblay JM; Gaspie K; Kudej RK; Vigdorovich V; Sather N; Jaskiewicz JJ; Tzipori S; Shoemaker CB
PLoS One; 2023; 18(11):e0291937. PubMed ID: 38011121
[TBL] [Abstract][Full Text] [Related]
14. Application Progress of the Single Domain Antibody in Medicine.
Tang H; Gao Y; Han J
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835588
[TBL] [Abstract][Full Text] [Related]
15. Alpaca (Lama pacos) as a convenient source of recombinant camelid heavy chain antibodies (VHHs).
Maass DR; Sepulveda J; Pernthaner A; Shoemaker CB
J Immunol Methods; 2007 Jul; 324(1-2):13-25. PubMed ID: 17568607
[TBL] [Abstract][Full Text] [Related]
16. Antibody Affinity Maturation Using Computational Methods: From an Initial Hit to Small-Scale Expression of Optimized Binders.
Medagli B; Soler MA; De Zorzi R; Fortuna S
Methods Mol Biol; 2023; 2552():333-359. PubMed ID: 36346602
[TBL] [Abstract][Full Text] [Related]
17. T-cells engineered with a novel VHH-based chimeric antigen receptor against CD19 exhibit comparable tumoricidal efficacy to their FMC63-based counterparts.
Nasiri F; Safarzadeh Kozani P; Rahbarizadeh F
Front Immunol; 2023; 14():1063838. PubMed ID: 36875091
[TBL] [Abstract][Full Text] [Related]
18. General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold.
Vincke C; Loris R; Saerens D; Martinez-Rodriguez S; Muyldermans S; Conrath K
J Biol Chem; 2009 Jan; 284(5):3273-3284. PubMed ID: 19010777
[TBL] [Abstract][Full Text] [Related]
19. A review on camelid nanobodies with potential application in veterinary medicine.
Tohidi E; Ghaemi M; Golvajouei MS
Vet Res Commun; 2024 Jun; ():. PubMed ID: 38869749
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
